Combined CRISPR/Cas9 data, human spatial transcriptomic data, and human and mouse RNA sequencing data led to the nomination of PDE10A as a potential haploinsufficient tumor suppressor in the 6q27 region. The gene discussed is PDE10A; the disease is neoplasm.